Christopher Shade, PhD, founder and CEO of Quicksilver Scientific, continues to be the driving force of development and innovation. Dr. Shade’s vast depth and breadth of knowledge, passion for healing, and intuitive understanding of chemistry and biology are reflected in Quicksilver Scientific’s well-designed detoxification protocols, unique supplement delivery systems, and patented mercury speciation test. Dr. Shade is a recognized expert on mercury and liposomal delivery systems. He has lectured and trained doctors in the U.S. and internationally on the subject of mercury, heavy metals, and the human detoxification system. Dr. Shade's current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals, such as liposomes and micro-emulsion systems, to address the growing need of high quality, affordable detoxification solutions.

Dr. Lexi Gonzales, ND, MS, IFMCP, is a clinician, educator, and implementation strategist working at the forefront of functional and longevity medicine. Trained in biochemistry, systems biology, and translational research, she develops practical frameworks that strengthen clinical reasoning and elevate patient care. As Senior Clinical Implementation and AI Specialist at OvationLab, she designs models and educational systems that help practitioners integrate emerging technologies with clarity and consistency. Her clinical background spans primary care within an insurance-based integrative model, multidisciplinary practice at Vida Integrated Health, and private functional medicine practice with a focus on hormonal and metabolic optimization, endometriosis, and fertility. She also served as IFM’s inaugural Medical Education Resident and later as Clinical Content Developer.

Tom Blue is a Founding Partner of OvationLab, a business advisory and clinical research firm that helps companies in natural products, testing, digital health, and medical devices successfully launch and commercialize within the healthcare professional channel. Since establishing Virginia’s first concierge medical practice in 2001, he has focused on designing and implementing innovative practice models that accelerate the translation of emerging best practices into real-world care. His latest venture, AndHealth—a root-cause, largely virtual clinical model backed in part by the AMA’s investment arm—closed the largest seed round in digital health in 2021 at $57M. Tom’s current work centers on the rapidly evolving longevity marketplace, clinical applications of AI, and scaling personalized nutritional supplementation.